COVID-19 vaccines safe for patients treated for lung cancer with immune checkpoint inhibitors
Analyses of the relation between people’s mobility and SARS-CoV-2 spread reveals three groups of countries
22 June 2022Most common allergies not linked to rheumatoid arthritis
22 June 2022COVID-19 vaccines safe for patients treated for lung cancer with immune checkpoint inhibitors
Cancer patients have received priority status to receive COVID-19 vaccinations but there is limited data regarding the safety and efficacy of the vaccines for patients treated for lung cancer with immune checkpoint inhibitors. Now, a new study published in the Journal of Thoracic Oncology found that vaccines are safe and effective for these patients.
